MENOAID

Serial Number 98882305
686

Registration Progress

Application Filed
Dec 3, 2024
Under Examination
Approved for Publication
Jul 1, 2025
Published for Opposition
Jul 1, 2025
Registered

Attorney Assistance

Important Deadline Approaching
Notice of Publication
Due: July 31, 2025 24 days remaining

Missing this deadline could result in abandonment or cancellation of your trademark.

Basic Information

Serial Number
98882305
Filing Date
December 3, 2024
Published for Opposition
July 1, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Jul 1, 2025
Application
Pending
Classes
005

Rights Holder

Purapharm International (H.K.) Limited

16
Address
HK Science Park, Pak Shek Kok
Rm 201-7, 2/F, Wireless Centre, Ph 1
Tai Po, NT
HK

Ownership History

Purapharm International (H.K.) Limited

Original Applicant
16
Tai Po, NT HK

Purapharm International (H.K.) Limited

Owner at Publication
16
Tai Po, NT HK

Legal Representation

Attorney
Rodney L Skoglund

USPTO Deadlines

Next Deadline
24 days remaining
Notice of Publication
Due Date
July 31, 2025
Extension Available
Until August 31, 2025

Application History

11 events
Date Code Type Description
Jul 1, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 1, 2025 PUBO A PUBLISHED FOR OPPOSITION
Jun 25, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 27, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 27, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED
May 27, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED
May 27, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN
May 27, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 22, 2025 DOCK D ASSIGNED TO EXAMINER
Dec 3, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 3, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Herbal extracts, other than essential oils, for medical purposes; medicinal herbs; medicinal herbal preparations for treating menopausal symptoms; medicinal herbal preparations; Chinese traditional medicinal herbs used to treat menopausal syndrome and symptoms; none of the foregoing relating to fertility stimulating hormones

Classification

International Classes
005